NCT06491160View on ClinicalTrials.gov

Performance and FMRI BOLD Signal Changes in Impulsive Patients

CompletedOBSERVATIONAL

Enrollment

20

Participants

Timeline

Start Date

August 6, 2024

Primary Completion Date

October 30, 2024

Study Completion Date

October 30, 2024

Conditions

Attention Deficit Hyperactivity DisorderBorderline Personality Disorder

Trial Locations (1)

Unknown

Charité Research Organisation GmbH, Berlin

Sponsors

Collaborators (1)

Boehringer Ingelheim

All Listed Sponsors

collaborator

Charité Research Organisation GmbH

OTHER

collaborator

Boehringer Ingelheim

INDUSTRY

lead

Simone Grimm

OTHER

NCT06491160 - Performance and FMRI BOLD Signal Changes in Impulsive Patients | Biotech Hunter | Biotech Hunter